ArticleBMC gastroenterology2025
A socioeconomic perspective on the global burden of gastroesophageal reflux disease (1990-2021): findings from the GBD 2021.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastroesophageal reflux disease (GERD) constitutes a global public health challenge, afflicting individuals across nearly all age groups over the long term. However, few systematic investigations have assessed the associated disease burden from a socioeconomic perspective.
methodsGERD data were extracted from the GBD 2021 database, encompassing data from the global level, 5 sociodemographic index (SDI) groups, and 24 GBD regions for the period of 1990-2021. Estimated annual percentage changes (EAPCs) were calculated to characterize temporal trends. Health inequality analysis, decomposition analysis and frontier analysis were employed to evaluate the disease burden.
resultsFrom 1990 to 2021, the global number of incident cases increased from 180 million to 324 million, the number of prevalent cases increased from 451 million to 826 million, and the number of disability-adjusted life years increased from 3.47 million to 6.34 million. Compared with men, women presented a greater disease burden. The SDI showed a weak negative correlation with the disease burden, and the burden remained concentrated among low-SDI populations over the 30-year period (CII= -0.04), with no improvement observed. Decomposition analysis revealed that population growth (64.58%‒68.46%) and aging (22.85%‒29.53%) were the primary drivers of the increased burden, whereas epidemiological changes in high-SDI regions had negative effects. Frontier analysis indicated that regions with an SDI > 0.75 had the greatest potential for reduction.
conclusionThe global disease burden of GERD has continued to increase, with significant disparities across geographical, socioeconomic, and demographic characteristics. This study provides a scientific basis for formulating targeted public health strategies and alleviating health inequalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.